1222 Results

People

  1. Sadelain
    Sadelain
  2. Scheinberg
    Scheinberg
  3. Riviere
    Riviere
  4. Brentjens
    Brentjens
  5. Mcdevitt
    Mcdevitt
  6. Larson
    Larson
  7. Park
    Park
  8. Wang
    Wang
  9. Jurcic
    Jurcic
  10. Dao
    Dao

Groups

  1. Center for Hematologic Malignancies (1222)
  2. Department of Medicine (1222)
  3. GSK Faculty (1222)
  4. Hematologic Malignancies, Division of (1222)
  5. Molecular Pharmacology and Chemistry Program Faculty (1222)
  6. Sloan Kettering Institute Faculty (1222)
  7. Hematologic Malignancies Research (1112)
  8. Adult Leukemia (686)
  9. Tow Center for Developmental Oncology (TCDO) (630)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (524)
  1. "Center for Hematologic Malignancies"
  2. "Hematologic Malignancies, Division of"
  3. "GSK Faculty"
  4. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (645)
  2. Meeting Abstract (537)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Review (8)
  6. Editorial (4)
  7. Research Letter (3)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (1222)
  2. Department of Medicine (1222)
  3. GSK Faculty (1222)
  4. Hematologic Malignancies, Division of (1222)
  5. Molecular Pharmacology and Chemistry Program Faculty (1222)
  6. Sloan Kettering Institute Faculty (1222)

More Groups

People
  1. Michel Sadelain (571)
  2. David Scheinberg (493)
  3. Isabelle Riviere (199)
  4. Renier Brentjens (130)
  5. Michael Mcdevitt (117)
  6. Steven Larson (116)

More People

Years
  1. 2024 (5)
  2. 2023 (34)
  3. 2022 (33)
  4. 2021 (40)
  5. 2020 (34)
  6. 2019 (38)

More Years

Publications
  1. Blood (282)
  2. Molecular Therapy (59)
  3. Cancer Research (51)
  4. Journal of Nuclear Medicine (50)
  5. Journal of Clinical Oncology (49)
  6. Clinical Cancer Research (25)

More Publications

Publishers
  1. American Society of Hematology (285)
  2. Nature Publishing Group (177)
  3. American Association for Cancer Research (125)
  4. Elsevier Inc. (80)
  5. American Society of Clinical Oncology (51)
  6. Society of Nuclear Medicine (50)

More Publishers

Results (1222)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
    Journal Article

    Amor, C.; Fernández-Maestre, I.; Chowdhury, S.; Ho, Y. J.; Nadella, S.; Graham, C.; Carrasco, S. E.; Nnuji-John, E.; Feucht, J.; Hinterleitner, C.; more...
    Nature Aging (2024)

    Fulltext@MSK | Save
  • A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
    Journal Article

    Dao, T.; Xiong, G.; Mun, S. S.; Meyerberg, J.; Korontsvit, T.; Xiang, J.; Cui, Z.; Chang, A. Y.; Jarvis, C.; Cai, W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Alpha-emitting radionuclides: Current status and future perspectives
    Review

    Miederer, M.; Benešová-Schäfer, M.; Mamat, C.; Kästner, D.; Pretze, M.; Michler, E.; Brogsitter, C.; Kotzerke, J.; Kopka, K.; Scheinberg, D. A.; more...
    Pharmaceuticals (2024)

    Fulltext@MSK | Save
  • Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP
    Journal Article

    Morales, A. E.; Gumenick, R.; Genovese, C. M.; Jang, Y. Y.; Ouedraogo, A.; de Garayo, M. I.; Pannellini, T.; Patel, S.; Bott, M. E.; Alvarez, J.; more...
    PLoS Pathogens (2024)

    Fulltext@MSK | Save
  • Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function
    Journal Article

    Jain, N.; Zhao, Z.; Koche, R. P.; Antelope, C.; Gozlan, Y.; Montalbano, A.; Brocks, D.; Lopez, M.; Dobrin, A.; Shi, Y.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Potent and target specific cytotoxicity of PRAME TCR mimic CAR T cells in KMT2A-rearranged AML patient-derived xenograft model
    Meeting Abstract

    Kirkey, D. C.; Robinson, L.; Hylkema, T.; Loeb, A.; Ries, R. E.; McKay, C.; Root, C.; Pardo, L.; Loeb, K. R.; Le, Q.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • GLUT1 overexpression enhances 19-28z CAR-T cell expansion and metabolic fitness
    Meeting Abstract

    Shi, Y.; Kotchetkov, I. S.; Hanina, S. A.; Sadelain, M.
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Role of cell therapy product characteristics in patient response to TAK-940 (CD19(T2)28z1xx chimeric antigen receptor (CAR) T): Biomarker analyses from a phase i study in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Sundaresan, V.; Senechal, B.; Wang, X.; Kashyap, S.; Tong, E.; Joshi, A.; Dash, A.; Sellner, L.; Chen, S.; McAvoy, D.; more...
    Blood (2023)

    Fulltext@MSK | Save